Literature DB >> 70930

Photochemotherapy of psoriasis with relevance to 8-methoxypsoralen plasma level and low intensity irradiation.

P Thune, G Volden.   

Abstract

The 8-methoxypsoralen (8-MOP) plasma level was determined in 31 patients during treatment with PUVA (psoralen + UVA light). The UVA light source was of a low intensity type, giving only 2 mW/sec/cm2 and required an irradiation time of 30 minutes. The lesions of 19 patients healed completely. Following an oral dose regimen adjusted to the patient's weight, the 8-MOP values at 2 hours varied from 2 ng/ml to 167 ng/ml (mean 56 ng/ml). There was no clearcut relation between the 8-MOP plasma level and the clinical response but in 9 patients there was a prompt response to treatment when the dose of psoralen was increased by 10 mg. In 5 patients the 8-MOP plasma levels was determined hourly for the first 4 hours and showed a peak at 2 hours except in one patient with very low values who had a peak at 4 hours. The augmentation of pigmentation was measured by means of reflectometry on three univolved areas. Two peaks were observed--one during the first week and the other after 2--3 weeks of therapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70930

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  11 in total

1.  [Skin impedance and phoreographic index in psoriasis. Relationship with action kinetics of three treatments].

Authors:  M Cambrai; E J Clar; E Grosshans; C Altermatt
Journal:  Arch Dermatol Res       Date:  1979-03-31       Impact factor: 3.017

2.  [8-Methoxypsoralen (8-MOP)-a new galenic form and its relation to 8-MOP serum levels (author's transl)].

Authors:  V Nitsche; M Raff; H Bardach
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

3.  Microenema of 8-methoxypsoralen in photochemotherapy of psoriasis.

Authors:  A H Siddiqui; L Stolk; H R Korthals Altes-Levij van Vinninghe; A Kammeijer; R H Cormane
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

4.  Intraindividual variations of 8-methoxypsoralen plasma levels.

Authors:  M Schäfer-Korting; H C Korting
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

5.  Determination of 8-methoxypsoralen levels in plasma and skin suction blister fluid by a new sensitive fluorodensitometric method.

Authors:  H C Korting; M Schäfer-Korting; E Roser-Maass; E Mutschler
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

6.  Variations in skin photosensitization during repeated oral 8-methoxypsoralen medication.

Authors:  C T Jansén; G Wilén; R Paul
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

Review 7.  Clinical pharmacokinetics of methoxsalen and other psoralens.

Authors:  F A de Wolff; T V Thomas
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

8.  Serum levels of 8-methoxypsoralen in psoriasis patients using a new fluorodensitometric method.

Authors:  M J Herfst; E A Koot-Gronsveld; F A de Wolff
Journal:  Arch Dermatol Res       Date:  1978-06-29       Impact factor: 3.017

9.  Pharmacokinetic and clinical comparison of two 8-methoxypsoralen brands.

Authors:  K E Andersen; T Menne; M Gammeltoft; N Hjorth; E Larsen; P Solgaard
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

10.  Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid.

Authors:  J Lauharanta; T Juvakoski; L Kanerva; A Lassus
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.